title: [Treatment for crush syndrome of extremities with antioxidants].
abstract: OBJECTIVE
  To study the clinical therapeutic effect of antioxidants assistant treatment of extremities crush syndrome (CS)in order to find new therapy.
  
  
  METHODS
  Twenty-one male patients (aged from 24 to 48 years, mean 36 years) were treated with the next antioxidants in early stage: (1) 20% Mannitol 250 ml intravenous drip in 30 minutes (one time per 6 to 8 h). (2) Sodium aescinate 20 mg, Salvia Miltiorrhiza 20 ml were dissolved respectively in isotonic saline or 5% glucose 200 ml and dripped by intravenous drip (50 to 60 drips per minute). The drugs were used for 5 to 7 days (one time per day). Basifying urine, keeping the nagative liquid banlance and electrolyte banlance, preventing infection and hold out treatment were done. When the pressure of muscular osteofascial compartment was more than 30 mmHg, deep fasia was cut to decompress timely and the above-mentioned drugs were continuously applied for patients.
  
  
  RESULTS
  Myoglobin urine of 21 cases died out after 2 to 3 days, of them, 13 cases were performed to decompress. After open decompression, 2 cases suffered from amputation because of long time of ischemia, 2 cases took place slight dysfunction of lower limbs, one hand had ischemia muscular contracture in 1 case and one foot down-vertical in 1 case. After followed-up of 8 months to 1 year, according to the function standard, the result were excellent in 8 cases, good in 7 cases, fair in 2 cases, poor in 4 cases. The excellent and good rate was about 71.4% (15/21).
  
  
  CONCLUSIONS
  After extremities crushed for long time, application of antioxidents as early as possible can decrease significantly the incidence and invalidity rate of CS.
authors.affiliation: Department of Orthopaedics, Coal General Hospital of Henan Province, Zhengzhou 450002, Henan, China.
authors.forename: Chang-Guo
authors.initials: CG
authors.lastname: Fu
mesh_terms: D000328:Adult; D000975:Antioxidants / Q000008:administration & dosage / Q000627:therapeutic use*; D003444:Crush Syndrome / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D005121:Extremities / Q000293:injuries*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009212:Myoglobinuria / Q000150:complications / Q000652:urine; D055815:Young Adult
chemical_list: D000975:Antioxidants